Michael J. Deppe - Nov 6, 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
Sean D. Mersten, Attorney in Fact for Michael J. Deppe
Stock symbol
DGX
Transactions as of
Nov 6, 2024
Transactions value $
-$2,889,123
Form type
4
Date filed
11/7/2024, 05:21 PM
Previous filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $615K +8.64K +24.71% $71.17 43.6K Nov 6, 2024 Direct F1
transaction DGX Common Stock Options Exercise $673K +10.1K +23.22% $66.51 53.7K Nov 6, 2024 Direct F1
transaction DGX Common Stock Sale -$321K -2.1K -3.91% $152.70 51.6K Nov 6, 2024 Direct F1, F2
transaction DGX Common Stock Sale -$370K -2.4K -4.65% $153.98 49.2K Nov 6, 2024 Direct F1, F3
transaction DGX Common Stock Sale -$640K -4.14K -8.41% $154.74 45.1K Nov 6, 2024 Direct F1, F4
transaction DGX Common Stock Sale -$397K -2.6K -5.77% $152.71 42.5K Nov 6, 2024 Direct F1, F5
transaction DGX Common Stock Sale -$359K -2.33K -5.49% $154.03 40.1K Nov 6, 2024 Direct F1, F3
transaction DGX Common Stock Sale -$803K -5.19K -12.93% $154.74 34.9K Nov 6, 2024 Direct F1, F6, F7
holding DGX Common Stock 691 Nov 6, 2024 401(k) F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$615K -8.64K -100% $71.17 0 Nov 6, 2024 Common Stock 8.64K $71.17 Direct F1, F9
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$673K -10.1K -100% $66.51 0 Nov 6, 2024 Common Stock 10.1K $66.51 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F2 This transaction was executed in multiple trades at prices ranging from $152.400 to $153.200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $154.460 to $155.180. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $152.400 to $153.170. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $154.460 - $155.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
F8 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F9 The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.
F10 The options vested in three annual installments beginning with the first on February 26, 2017, the second on February 25, 2018 and the final on February 25, 2019.